Mike Czapar | IR |
Enrique Conterno | President, Lilly Diabetes and Lilly USA |
Ilya Yuffa | VP, U.S. Diabetes |
Brad Woodward | Global Development Leader, Incretins |
Jeffrey Emmick | VP, Diabetes Product Development |
Louise Chen | Cantor Fitzgerald |
Chris Schott | JP Morgan |
David Risinger | Morgan Stanley |
Terence Flynn | Goldman Sachs |
Umer Raffat | Evercore |
Vamil Divan | Credit Suisse |
Seamus Fernandez | Guggenheim |
Steve Scala | Cowen |
Jason Gerberry | Bank of America |
Andrew Baum | Citi |
Navin Jacob | UBS |
Damien Conover | Morningstar |
Ladies and gentlemen thank you for standing by. Welcome to Lilly Diabetes Update. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] Also as a reminder, today's teleconference is being recorded.